Start
September 27, 2025 - 4:00 pm
End
November 1, 2025 - 4:00 pm
Join us online for a live free webinar series in conjunction with FELAEN, focusing on Osteoporosis across three sequential webinars with world-class speakers who will address topics from research to clinical application, promoting timely diagnosis and its treatment.
Don’t miss the opportunity to learn about the advances in the field, recognize the importance of a sequential treatment and the opportunity to ask the experts any questions you may have.
Osteoporosis is a disease recognised for its impact on quality of life. The World Health Organisation (WHO) has established Monday, 20 October as a day to promote timely diagnosis and treatment of Osteoporosis.
From late September to early November, ISE and FELAEN, will be marking this occasion with the following sessions as part of the Osteoporosis Webinar Series:
The Wnt-signaling pathway with focus on DKK-1
Saturday, 27 September 2025 – 4pm (CEST) / 8am (CDMX)
Speaker: Professor Robert Stad (Switzerland)
Moderators: Vivien Lim (Singapore) and Pilar De la Peña (Mexico)
This webinar will focus on advancing current basic pathway research knowledge in Osteoporosis.
Learning Objectives:
- Better understand the pleiotropic effects of DKK-1 (basics of Bone Physiology, bone loss, bone erosions, fracture healing)
- Knowing how Wnt signaling pathway works
- Updating regulation on bone metabolism
Denosumab and Romosozumab
Saturday, 11 October 2025 – 4pm (CEST) / 8am (CDMX)
Speaker: Professor César Libanati (USA)
Moderators: Vivien Lim (Singapore) and Pilar De la Peña (Mexico)
This webinar will focus on understanding the clinical indications, time of use, discontinuation, sequential therapy.
Learning Objectives:
- Better understand how Romosozumab and Denosumab were born
- How long is recommended to use them in our patients
- How bad is the discontinuation, and if this happens, then what to expect and what to do
A global overview of currently available osteoporosis treatments
Saturday, 1 November 2025 – 3pm (CET) / 8am (CDMX)
Speaker: Professor Michael McClung (USA)
Moderators: Vivien Lim (Singapore) and Claudia Campusano (Chile)
This webinar will focus on understanding what drug to use to whom and how long.
Learning Objectives:
- How long should osteoporosis treatment be given?
- Is T-score still the gold standard to follow treatment efficacy in our patients?
- What should we expect if a patient previously has been treated with intermittent anabolic and/or antiresorptive? Is it possible to use one anabolic followed by another?